Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
09/2003
09/12/2003CA2478618A1 Isoquinoline derivatives
09/12/2003CA2477874A1 Expression cassette for persistence of expression of a gene of interest in muscle cells
09/12/2003CA2477721A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003CA2477715A1 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
09/12/2003CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477391A1 Method of treating osteoarthritis
09/12/2003CA2476757A1 Nitrogen-containing heterocyclic compound
09/12/2003CA2476410A1 Methods to increase or decrease bone density
09/12/2003CA2455447A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/11/2003WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
09/11/2003US20030171584 6-Substituted pyrido-pyrimidines
09/11/2003US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
09/11/2003US20030171389 Anticancer agents; bone disorders; antiarthritic agents
09/11/2003US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases
09/11/2003US20030171357 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/11/2003US20030171342 Novel 16-ene-C25-oxime and 16-ene- C-25-oxime ether analogs of 1 alpha ,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24.
09/11/2003US20030171337 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
09/11/2003US20030171304 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
09/11/2003US20030171300 Treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary
09/11/2003US20030171288 Methods for the prevention and treatment of a variety of mammalian conditions manifested by loss of bone mass, including osteoporosis. The present invention provides methods of using PTHrP, or analogs thereof, for the treatment of
09/11/2003US20030171282 Systemic delivery of parathyroid hormone to a mammalian host is accomplished by inhalation through the mouth of a dispersion of an N-terminal fragment of PTH. It has been found that such respiratory delivery of the PTH fragment
09/11/2003US20030171280 Compositions and methods for modulation of immune responses
09/11/2003US20030171271 Therapeutic application in the treatment of conditions including cancer, macular degeneration and retinopathies. Also included are methods of treating a patient having a pathological condition characterized by an increase in
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
09/11/2003US20030170839 Type 2 cytokine receptor and nucleic acids encoding same
09/11/2003US20030170685 Canine hepatocyte growth factor
09/11/2003US20030170648 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression
09/11/2003US20030170319 Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
09/11/2003US20030170303 That has low water solubility such as celecoxib; and a release- extending polymer.
09/11/2003US20030170292 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
09/11/2003US20030170289 Injectable depot compositions and uses thereof
09/11/2003US20030170217 Bifidobacterium in the treatment of inflammatory disease
09/11/2003US20030170212 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
09/11/2003US20030170208 To promote osteogenesis and therefore uses include fracture healing and repair and acceleration of fracture healing
09/10/2003EP1342796A2 Compound for the treatment of paget's disease of bone
09/10/2003EP1342720A2 Epoxysuccinamide derivatives
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341914A2 Regulation of angiogenesis with zinc finger proteins
09/10/2003EP1341817A2 Tff peptides
09/10/2003EP1341814A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/10/2003EP1341811A2 Orally ingestible preparation of mistletoe lectins and method
09/10/2003EP1341782A2 Inhibitors of p38 kinase
09/10/2003EP1341768A1 Therapeutic benzimidazole compounds
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341765A1 Therapeutic compounds
09/10/2003EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
09/10/2003EP1341754A1 Substituted anthranilic acids
09/10/2003EP1341552A2 Treatment of immune-mediated diseases by oral administration of plasma fractions
09/10/2003EP1341546A2 Kyberdrug as autovaccines with immune-regulating effects
09/10/2003EP1341540A2 Tyrosine kinase inhibitors
09/10/2003EP1341539A1 Anti-inflammatory agents
09/10/2003EP1341537A2 Pharmaceutically active isoindoline derivatives
09/10/2003EP1341533A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
09/10/2003EP1341526A2 Pharmaceutical compositions for the oral delivery of pharmacologically active agents
09/10/2003EP1341497A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
09/10/2003EP1194401B1 Diacylhydrazine derivatives
09/10/2003EP1140818B1 Amidomalonamides and their use as inhibitors of matrix metalloproteinase
09/10/2003EP1085816B1 Dietary supplement derived from fermented milks for the prevention of osteoporosis
09/10/2003EP1023063B1 INDENO[1,2-c], NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES
09/10/2003EP1007632A4 Isolation of bone and cartilage precursor cells
09/10/2003EP0934264B1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
09/10/2003EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
09/10/2003CN1441843A Extracellular matrix protein
09/10/2003CN1441803A Indoloquinazolinones
09/10/2003CN1441787A Modulators of TNF-alpha signaling
09/10/2003CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues
09/10/2003CN1441782A N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
09/10/2003CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
09/10/2003CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
09/10/2003CN1441770A Modified forms of pharmacologically active agents and uses therefor
09/10/2003CN1441675A Compositions and methods for achieving immune suppression
09/10/2003CN1441674A Diphosphonate solutions
09/10/2003CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors
09/10/2003CN1441667A Pharmaceutical compositions
09/10/2003CN1441666A Macromolecular drug complexes and compositions containing same
09/10/2003CN1440971A Vitronectin receptor antagnist, its preparation and use
09/10/2003CN1440790A Application of atractylodes rhizome oil in preparing medicine for osteoporosis
09/10/2003CN1440788A Bone injury treating Chinese medicine capsule
09/10/2003CN1440787A Medicine for treating rheumatic and rheumatoid diseases
09/10/2003CN1440774A Ointment for treating burns and scalds, sore, bone tuberculosis and wounds
09/10/2003CN1440768A Chinese medicine for treating rheumatic diseases and its prepn
09/10/2003CN1440744A Coated nano melatonin composite health tonic
09/10/2003CN1120838C Dihydrobenzofuran compounds useful as anti-inflammatong agents
09/10/2003CN1120725C Medicine for treating osteoporosis and hyperosteogeny and preparing process thereof
09/10/2003CN1120720C Chinese medicine capsule for curing prolapse of lumber intervertebral disc and preparing method thereof
09/10/2003CN1120717C Plaster
09/10/2003CN1120716C Plaster for curing bony spur and its preparing process
09/10/2003CN1120714C Chinese medicine preparation for curing necrosis of femoral head and its preparing method
09/09/2003US6617431 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
09/09/2003US6617426 Peptide analogs of given formula; useful in treating neurodegenerative, autoimmune, cognitive disorders, stroke and traumatic injury
09/09/2003US6617359 4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
09/09/2003US6617352 Compounds and methods for the inhibition of the expression of VCAM-1
09/09/2003US6617348 Treating or preventing osteoporosis
09/09/2003US6617324 Substituted pyrazoles as p38 kinase inhibitors
1 ... 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 ... 820